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Introduction
Potential participants in randomised controlled trials are 
given information that is often long, technical and difficult to 
navigate1–3. Consequently, they may lack understanding of 
important details about the trial1,4,5, which limits their ability to 
make an informed decision about consent.
Improving information materials is possible through 
optimisation and user-testing. This involves making changes 
to the design and text based on good practice in information 
design and people’s ability to find and understand information 
during testing6. Materials revised after user-testing have been 
shown to be preferred7,8, although a recent review concluded 
that optimised information has little or no impact on trial 
recruitment9. However, the evidence base remains limited10–13, 
and a recent ‘review of reviews’ reported that information for 
patients can be a facilitator of research participation14.
Study aims
This embedded study within a trial (SWAT) assesses whether 
optimisation of patient information materials through user 
testing could increase participant recruitment to the CASPER 
study15.
Methods
Design
The SWAT was conducted within CASPER, which investigated 
the effectiveness of behavioural activation in patients aged 
65 years or older with sub-threshold levels of depression15. 
CASPER used a cohort multiple randomised controlled trial 
design16.
Participants
Participants were registered patients at one of six UK medical 
practices in Durham, Harrogate, Leeds and York. They were 
included if they were potentially eligible for CASPER.
Intervention
All participants in the SWAT were posted an invitation letter, 
participant information sheet (PIS), screening questionnaire 
and consent form for the CASPER trial. The control group 
received the standard CASPER developed PIS (see Extended 
data)17 whilst the intervention group were sent an optimised 
version (see Extended data)18 developed through three rounds of 
user testing and revision.
Patients returned the questionnaire and a consent form 
indicating a willingness to participate, after which they were 
recruited to the CASPER cohort. Following a telephone 
diagnostic interview, eligible patients were recruited to the 
CASPER intervention trial.
User testing
User testing involved 30 people reflecting the CASPER target 
population. In the first round of testing, 10 participants read 
the standard invitation letter and PIS. They were then asked 
to locate and demonstrate their understanding of 18 items 
of information within the PIS (on the study’s nature and 
purpose; process and meaning of consent; study procedures; 
nature of the CASPER trial intervention). The PIS was then 
revised based on participant responses. A second round of 
testing was completed, in which 10 new participants read the 
invitation letter and a revised PIS and were asked to find and 
show understanding of the same 18 information items. The 
PIS was further revised and tested on 10 new participants through 
the same 18 information items.
Through testing, changes to the PIS included adding a title 
page, a summary of key points and a contents page, highlight-
ing headings using colour and larger font, and simplifying 
wording. The final optimised PIS was printed as an A4 booklet 
(Figure 3).
Outcomes
The primary outcome measure was the proportion of patients in 
each group who were recruited to the CASPER trial. The sec-
ondary outcomes were (i) the proportion of patients recruited 
to the CASPER cohort, and (ii) the proportion of invited 
patients returning forms to express interest in participation 
in CASPER.
Sample size
It was predicted that 30% of invited patients would return 
the consent form and indicate interest in CASPER participa-
tion, of whom 20% (600) would be eligible to take part in 
the CASPER trial. An improvement in response rate of 10% 
(i.e. from 30% to 33% participants) would be a significant 
increase in uptake. A sample size of 8,000 potential participants 
would be sufficient at 80% power to detect a difference of 10% 
in recruitment rate.
Randomisation
Individual patients were allocated randomly (1:1) to receive either 
the standard or optimised PIS by an independent statistician 
at York Trials Unit.
Statistical analysis
Odds ratios (ORs) and corresponding 95% confidence inter-
vals (CIs) were calculated to compare the proportion of 
patients from each group that were recruited to the CASPER 
trial; recruited to the CASPER cohort; or expressed inter-
est in participation. Analyses were conducted in Stata version 
14.2.
Approvals
CASPER and the SWAT were approved by the NHS Leeds 
North-East Research Ethics Committee (10/H1306/61).
Results
Overall, 11,531 patients were invited to participate19; 5,765 
(50.0%) were randomised to the optimised PIS and 5,766 (50.0%) 
to the standard PIS (Figure 1).
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A total of 2,169 patients returned the consent form indicat-
ing a willingness to take part: 1,102 (19.1%) in the optimised 
PIS group and 1,067 (18.5%) in the standard PIS group (odds 
ratio (OR) 1.04; 95% confidence interval (CI) 0.95 to 1.14; 
p=0.402).
A total of 229 patients were recruited to the CASPER trial: 
116 (2.0% of those invited) in the optimised PIS group and 113 
(1.9%) in the standard PIS group (OR 1.027; 95% CI 0.79 to 1.33; 
p=0.202).
In total, 1,667 patients expressed interest in participating but 
were ineligible for the CASPER trial and were recruited to 
the CASPER cohort: 851 (14.8% of those invited) in the opti-
mised PIS group, and 816 (14.1%) in the standard PIS group 
(OR 1.05; 95% CI 0.95 to 1.16).
Discussion
Optimisation of the PIS resulted in no statistically significant 
difference in the rates of recruitment to the CASPER trial or 
CASPER cohort, or rates of consent form returns. This is con-
sistent with previous research9, including other embedded 
trials within the MRC START programme, which have observed 
little or no effect on recruitment11–13,20.
Whilst there was no impact on recruitment, the optimised mate-
rials may have improved understanding of the trial thus ena-
bling patients to make a more informed decision. Improved 
comprehension could also increase retention, due to greater 
understanding of the trial prior to recruitment. These outcomes 
were not assessed and further research examining this is 
warranted.
Figure 1. Flow diagram of recruitment to the CASPER trial.
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Conclusion
Optimised patient information materials did not increase recruit-
ment to the host trial or expressions of interest in participation.
Data availability
Underlying data
Figshare: CASPER SWAT data.csvCASPER SWAT recruitment 
data and evaluated information sheets. https://doi.org/10.6084/
m9.figshare.1230267220.
This project contains the underlying data
Extended data
Figshare: Figure 2 CASPER PIS (original). https://doi.org/10.6084/
m9.figshare.1230267517.
This file is the original CASPER participant information sheet.
Figshare: Figure 3 CASPER PIS (revised). https://doi.org/10.6084/
m9.figshare.1230267818.
This file is the revised CASPER participant information sheet.
Reporting guidelines
Figshare: CONSORT checklist for ‘Optimised patient 
information materials and recruitment to a study of behavioural 
activation in older adults: an embedded study within a trial’. 
https://doi.org/10.6084/m9.figshare.12312206.v121.
Data are available under the terms of the Creative Commons 
Attribution 4.0 International license (CC-BY 4.0).
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